Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone for postoperative emergence delirium in children undergoing tonsil and adenoid surgery
ChiCTR2300076528Phase 4Not yet recruiting
- Sponsor
- Anhui Provincial Children's Hospital
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxycodone in Emergence agitation (EA) (3 arms), sponsored by Anhui Provincial Children's Hospital. Primary endpoints: Incidence of emergence delirium and Serum MCP-1 concentration. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
oxycodone
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2300076528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076528.